Skip to main content

Table 3 Incident diseases, subjective health, and subjective memory impairment at follow-up comparing participants with and without SARS-CoV-2 infection

From: Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up

 

Infection at baseline (n = 350)

No infection (n = 4467)

n

% (95% CI)

Odds ratio (95% CI)

n

% (95% CI)

Odds ratio (95% CI)

Incident diagnosed diseases

 Cardiovascular/metabolic disease

22

6.5 (4.3–9.6)

1.68 (1.04–2.71)

177

4.0 (3.5–4.7)

reference

 Lung disease

11

3.2 (1.8–5.7)

3.50 (1.73–7.09)

49

1.1 (0.8–1.5)

reference

 Gastrointestinal disease

8

2.3 (1.2–4.6)

0.75 (0.36–1.56)

134

3.1 (2.6–3.6)

reference

 Liver/kidney disease

9

2.7 (1.4–5.0)

3.70 (1.69–8.08)

39

0.9 (0.7–1.2)

reference

 Neurological disease

6

1.8 (0.8–3.9)

1.86 (0.75–4.61)

40

0.9 (0.7–1.2)

reference

 Mental disease

9

2.7 (1.4–5.0)

0.93 (0.46–1.91)

140

3.2 (2.7–3.8)

reference

Subjective measures

 Current subjective health: fair/bad/very bad

67

19.3 (15.5–23.8)

1.91 (1.39–2.64)

579

13.0 (12.1–14.1)

reference

 Subjective memory impairment

89

25.7 (21.4–30.6)

2.27 (1.74–2.98)

633

14.3 (13.3–15.4)

reference

  1. Odds ratio and 95% confidence interval (95% CI) are derived from logistic regression models adjusted for the same variables as in Table 2. Missings for cardiovascular/metabolic disease n = 80, lung disease n = 65, gastrointestinal disease n = 92, liver/kidney disease n = 98, neurological disease n = 77, mental disease n = 130, subjective health n = 31, subjective memory impairment n = 45